Recombinant Human TGFa Protein，His

Transforming Growth Factor Alpha (TGFa) is a crucial cytokine involved in various physiological processes, including cell proliferation, differentiation, and survival. It exerts its effects primarily through the epidermal growth factor receptor (EGFR) pathway, playing a significant role in embryonic development and tissue regeneration. Dysregulation of TGFa has been implicated in several diseases, particularly cancer, where it can promote tumor growth and metastasis by enhancing cellular proliferation and influencing the tumor microenvironment. The recombinant production of TGFa has garnered significant interest due to its potential applications in therapeutic interventions and tissue engineering. By utilizing advanced biotechnological methods, researchers aim to produce functional TGFa proteins that can be utilized in both in vitro and in vivo studies. Understanding the structure-function relationship of TGFa and its interactions with cellular receptors is essential for elucidating its role in disease mechanisms and developing targeted therapies. Additionally, the ability to produce TGFa in a recombinant form allows for the standardization of doses and enhances the reproducibility of experiments, facilitating drug development. Overall, ongoing research into TGFa recombinant proteins promises to advance our understanding of its biological significance and improve treatment strategies for various diseases, particularly in oncology and regenerative medicine.